• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在前脑α-突触核蛋白小鼠模型中模板化包涵体的形成与亮氨酸丰富重复激酶2(LRRK2)无关。

Formation of templated inclusions in a forebrain α-synuclein mouse model is independent of LRRK2.

作者信息

Dues Dylan J, Ma Yue, Nguyen An Phu Tran, Offerman Alina V, Beddows Ian, Moore Darren J

机构信息

Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, USA.

Department of Epigenetics, Van Andel Institute, Grand Rapids, MI, USA.

出版信息

Neurobiol Dis. 2023 Nov;188. doi: 10.1016/j.nbd.2023.106338. Epub 2023 Oct 29.

DOI:10.1016/j.nbd.2023.106338
PMID:38435455
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10906965/
Abstract

Leucine-rich repeat kinase 2 (LRRK2) and α-synuclein share enigmatic roles in the pathobiology of Parkinson's disease (PD). mutations are a common genetic cause of PD which, in addition to neurodegeneration, often present with abnormal deposits of α-synuclein in the form of Lewy-related pathology. As Lewy-related pathology is a prominent neuropathologic finding in sporadic PD, the relationship between LRRK2 and α-synuclein has garnered considerable interest. However, whether and how LRRK2 might influence the accumulation of Lewy-related pathology remains poorly understood. Through stereotactic injection of mouse α-synuclein pre-formed fibrils (PFF), we modeled the spread of Lewy-related pathology within forebrain regions where LRRK2 is most highly expressed. The impact of genotype on the formation of α-synuclein inclusions was evaluated at 1-month post-injection. Neither deletion of nor G2019S LRRK2 knockin appreciably altered the burden of α-synuclein pathology at this early timepoint. These observations fail to provide support for a robust pathophysiologic interaction between LRRK2 and α-synuclein in the forebrain . There was, however, a modest reduction in microglial activation induced by PFF delivery in the hippocampus of knockout mice, suggesting that LRRK2 may contribute to α-synuclein-induced neuroinflammation. Collectively, our data indicate that the pathological accumulation of α-synuclein in the mouse forebrain is largely independent of LRRK2.

摘要

富含亮氨酸重复激酶2(LRRK2)和α-突触核蛋白在帕金森病(PD)的病理生物学中具有神秘作用。LRRK2突变是PD常见的遗传病因,除神经退行性变外,常伴有以路易体相关病理形式存在的α-突触核蛋白异常沉积。由于路易体相关病理是散发性PD突出的神经病理学表现,LRRK2与α-突触核蛋白之间的关系备受关注。然而,LRRK2是否以及如何影响路易体相关病理的积累仍知之甚少。通过立体定向注射小鼠α-突触核蛋白预形成纤维(PFF),我们模拟了路易体相关病理在LRRK2表达最高的前脑区域内的传播。在注射后1个月评估LRRK2基因型对α-突触核蛋白包涵体形成的影响。在这个早期时间点,LRRK2基因敲除和G2019S LRRK2基因敲入均未明显改变α-突触核蛋白病理负担。这些观察结果不支持LRRK2与前脑α-突触核蛋白之间存在强大的病理生理相互作用。然而,在LRRK2基因敲除小鼠的海马中,由PFF递送诱导的小胶质细胞激活有适度降低,这表明LRRK2可能促成α-突触核蛋白诱导的神经炎症。总体而言,我们的数据表明小鼠前脑中α-突触核蛋白的病理积累在很大程度上独立于LRRK2。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4155/10906965/19ca537f18a6/nihms-1946363-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4155/10906965/8f356fa3e244/nihms-1946363-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4155/10906965/7426d990adfd/nihms-1946363-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4155/10906965/baa4c5f802b0/nihms-1946363-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4155/10906965/0f520c845f56/nihms-1946363-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4155/10906965/a489890adb09/nihms-1946363-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4155/10906965/2f7dc8ed46e1/nihms-1946363-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4155/10906965/ac45f6464542/nihms-1946363-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4155/10906965/2d57f1dc2972/nihms-1946363-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4155/10906965/19ca537f18a6/nihms-1946363-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4155/10906965/8f356fa3e244/nihms-1946363-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4155/10906965/7426d990adfd/nihms-1946363-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4155/10906965/baa4c5f802b0/nihms-1946363-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4155/10906965/0f520c845f56/nihms-1946363-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4155/10906965/a489890adb09/nihms-1946363-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4155/10906965/2f7dc8ed46e1/nihms-1946363-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4155/10906965/ac45f6464542/nihms-1946363-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4155/10906965/2d57f1dc2972/nihms-1946363-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4155/10906965/19ca537f18a6/nihms-1946363-f0009.jpg

相似文献

1
Formation of templated inclusions in a forebrain α-synuclein mouse model is independent of LRRK2.在前脑α-突触核蛋白小鼠模型中模板化包涵体的形成与亮氨酸丰富重复激酶2(LRRK2)无关。
Neurobiol Dis. 2023 Nov;188. doi: 10.1016/j.nbd.2023.106338. Epub 2023 Oct 29.
2
Formation of templated inclusions in a forebrain α-synuclein mouse model is independent of LRRK2.在前脑α-突触核蛋白小鼠模型中模板化包涵体的形成独立于亮氨酸重复激酶2(LRRK2)。
bioRxiv. 2023 Aug 20:2023.08.19.553965. doi: 10.1101/2023.08.19.553965.
3
Widespread distribution of α-synuclein oligomers in LRRK2-related Parkinson's disease.α-突触核蛋白寡聚体在与富亮氨酸重复激酶2(LRRK2)相关的帕金森病中的广泛分布。
Acta Neuropathol. 2025 May 2;149(1):42. doi: 10.1007/s00401-025-02872-9.
4
Abundant non-inclusion α-synuclein pathology in Lewy body-negative LRRK2-mutant cases.路易体阴性的LRRK2突变病例中存在大量非包涵体型α-突触核蛋白病理改变。
Acta Neuropathol. 2025 May 2;149(1):41. doi: 10.1007/s00401-025-02871-w.
5
Astrocytes carrying LRRK2 G2019S exhibit increased levels of clusterin chaperone via miR-22-5p and reduced ability to take up α-synuclein fibrils.携带LRRK2 G2019S的星形胶质细胞通过miR-22-5p表现出簇集蛋白伴侣水平升高,且摄取α-突触核蛋白原纤维的能力降低。
Acta Neuropathol Commun. 2025 May 12;13(1):98. doi: 10.1186/s40478-025-02015-x.
6
Widespread Distribution of α-Synuclein Oligomers in -related Parkinson's Disease.α-突触核蛋白寡聚体在帕金森病中的广泛分布
bioRxiv. 2024 Dec 20:2024.12.18.629265. doi: 10.1101/2024.12.18.629265.
7
Pathological α-synuclein elicits granulovacuolar degeneration independent of tau.病理性α-突触核蛋白引发颗粒空泡变性,与tau无关。
Transl Neurodegener. 2025 Jun 19;14(1):31. doi: 10.1186/s40035-025-00494-5.
8
GTP-binding inhibitors increase LRRK2-linked ubiquitination and Lewy body-like inclusions.GTP 结合抑制剂增加 LRRK2 相关泛素化和路易小体样包涵体。
J Cell Physiol. 2020 Oct;235(10):7309-7320. doi: 10.1002/jcp.29632. Epub 2020 Mar 17.
9
SynNeurGe: The road ahead for a biological definition of Parkinson's disease.SynNeurGe:帕金森病生物学定义的未来之路。
J Parkinsons Dis. 2024 Dec 8:1877718X241298194. doi: 10.1177/1877718X241298194.
10
Gba1 E326K renders motor and non-motor symptoms with pathological α-synuclein, tau and glial activation.Gba1 E326K会引发运动和非运动症状,并伴有病理性α-突触核蛋白、tau蛋白和神经胶质激活。
Brain. 2024 Dec 3;147(12):4072-4083. doi: 10.1093/brain/awae222.

引用本文的文献

1
Accumulation of LRRK2-associated phospho-Rab12 degenerative lysosomes in tauopathies.富含亮氨酸重复激酶2相关磷酸化Rab12的退行性溶酶体在tau蛋白病中的积累。
bioRxiv. 2025 Jun 9:2025.06.06.658328. doi: 10.1101/2025.06.06.658328.
2
LRRK2-mediated mitochondrial dysfunction in Parkinson's disease.帕金森病中由LRRK2介导的线粒体功能障碍
Biochem J. 2025 May 28;482(11):BCJ20253062. doi: 10.1042/BCJ20253062.
3
LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology progression.LRRK2 激酶抑制可逆转 G2019S 突变依赖性对 tau 病理进展的影响。

本文引用的文献

1
Hippocampal subfield vulnerability to α-synuclein pathology precedes neurodegeneration and cognitive dysfunction.海马亚区对α-突触核蛋白病变的易损性先于神经退行性变和认知功能障碍。
NPJ Parkinsons Dis. 2023 Aug 29;9(1):125. doi: 10.1038/s41531-023-00574-1.
2
Association of a common genetic variant with Parkinson's disease is mediated by microglia.常见遗传变异与帕金森病的关联是由小胶质细胞介导的。
Sci Transl Med. 2022 Jul 27;14(655):eabp8869. doi: 10.1126/scitranslmed.abp8869.
3
Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain.
Transl Neurodegener. 2024 Mar 4;13(1):13. doi: 10.1186/s40035-024-00403-2.
病理性α-突触核蛋白将表达 LRRK2 的促炎单核细胞募集到大脑中。
Mol Neurodegener. 2022 Jan 10;17(1):7. doi: 10.1186/s13024-021-00509-5.
4
Inhibition of LRRK2 kinase activity promotes anterograde axonal transport and presynaptic targeting of α-synuclein.抑制 LRRK2 激酶活性可促进α-突触核蛋白的顺行轴突运输和突触前靶向。
Acta Neuropathol Commun. 2021 Nov 8;9(1):180. doi: 10.1186/s40478-021-01283-7.
5
Computational modeling of tau pathology spread reveals patterns of regional vulnerability and the impact of a genetic risk factor.tau蛋白病理传播的计算模型揭示了区域易损性模式和遗传风险因素的影响。
Sci Adv. 2021 Jun 9;7(24). doi: 10.1126/sciadv.abg6677. Print 2021 Jun.
6
LRRK2 Ablation Attenuates Αlpha-Synuclein-Induced Neuroinflammation Without Affecting Neurodegeneration or Neuropathology In Vivo.LRRK2 消融在体内不影响神经退行性变或神经病理学情况下减轻 α-突触核蛋白诱导的神经炎症。
Neurotherapeutics. 2021 Apr;18(2):949-961. doi: 10.1007/s13311-021-01007-8. Epub 2021 Feb 16.
7
Differential cross-seeding properties of tau and α-synuclein in mouse models of tauopathy and synucleinopathy.在tau蛋白病和突触核蛋白病小鼠模型中tau蛋白和α-突触核蛋白的差异交叉播种特性。
Brain Commun. 2020 Jul 3;2(2):fcaa090. doi: 10.1093/braincomms/fcaa090. eCollection 2020.
8
α-Synuclein modulates tau spreading in mouse brains.α-突触核蛋白调节小鼠脑中 tau 的扩散。
J Exp Med. 2021 Jan 4;218(1). doi: 10.1084/jem.20192193.
9
LRRK2 mediates microglial neurotoxicity via NFATc2 in rodent models of synucleinopathies.在突触核蛋白病的啮齿动物模型中,LRRK2通过NFATc2介导小胶质细胞神经毒性。
Sci Transl Med. 2020 Oct 14;12(565). doi: 10.1126/scitranslmed.aay0399.
10
LRRK2 and Protein Aggregation in Parkinson's Disease: Insights From Animal Models.LRRK2与帕金森病中的蛋白质聚集:来自动物模型的见解
Front Neurosci. 2020 Jul 8;14:719. doi: 10.3389/fnins.2020.00719. eCollection 2020.